When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision-Making and Management of Chemicals?
Katie Coady, Patience Browne, Michelle R. Embry, Thomas Hill, Eeva Leinala, Thomas Steeger, L Maslankiewicz, Tom Hutchinson
Abstract
Open-access reader